Search Results

There are 25874 results for: content related to: “ROADMAP” Controversies

  1. You have free access to this content
    Clinical and Experimental Aspects of Olmesartan Medoxomil, a New Angiotensin II Receptor Antagonist

    Cardiovascular Drug Reviews

    Volume 22, Issue 4, December 2004, Pages: 285–308, Kazunori Yoshida and Masahiro Kohzuki

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3466.2004.tb00147.x

  2. You have free access to this content
    Immunopathogenesis of olmesartan-associated enteropathy

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 11-12, December 2015, Pages: 1303–1314, E. V. Marietta, A. M. Nadeau, A. K. Cartee, I. Singh, A. Rishi, R. S. Choung, T.-T. Wu, A. Rubio-Tapia and J. A. Murray

    Version of Record online : 1 OCT 2015, DOI: 10.1111/apt.13413

  3. You have full text access to this Open Access content
    Comparison of effects of azelnidipine and trichlormethiazide in combination with olmesartan on blood pressure and metabolic parameters in hypertensive type 2 diabetic patients

    Journal of Diabetes Investigation

    Volume 2, Issue 6, December 2011, Pages: 490–496, Hidenori Yoshii, Tomoya Mita, Junko Sato, Yuuki Kodama, Jong Bock Choi, Koji Komiya, Kazuhisa Matsumoto, Rei Kanno, Masahiko Kawasumi, Hajime Koyano, Takahisa Hirose, Tomio Onuma, Ryuzo Kawamori and Hirotaka Watada

    Version of Record online : 6 JUN 2011, DOI: 10.1111/j.2040-1124.2011.00135.x

  4. Cardiovascular and mortality risk in elderly Medicare beneficiaries treated with olmesartan versus other angiotensin receptor blockers

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 4, April 2014, Pages: 331–339, David J. Graham, Esther H. Zhou, Stephen McKean, Mark Levenson, Katlyn Calia, Kate Gelperin, Xiao Ding, Thomas E. MaCurdy, Chris Worrall and Jeffrey A. Kelman

    Version of Record online : 26 NOV 2013, DOI: 10.1002/pds.3548

  5. Cardiac mortality in users of olmesartan, other angiotensin-receptor blockers and angiotensin-converting enzyme inhibitors

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 4, April 2014, Pages: 348–356, Alexander M. Walker, Caihua Liang, C. Robin Clifford, Crawford Parker and Allen Feldman

    Version of Record online : 23 DEC 2013, DOI: 10.1002/pds.3558

  6. You have free access to this content
    Organic Anion Transporter 4-Mediated Transport of Olmesartan at Basal Plasma Membrane of Human Placental Barrier

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 9, September 2015, Pages: 3128–3135, Saki Noguchi, Tomohiro Nishimura, Ayasa Fujibayashi, Tetsuo Maruyama, Masatoshi Tomi and Emi Nakashima

    Version of Record online : 26 MAR 2015, DOI: 10.1002/jps.24434

  7. Pharmacokinetics of Amlodipine and Olmesartan After Administration of Amlodipine Besylate and Olmesartan Medoxomil in Separate Dosage Forms and as a Fixed-Dose Combination

    The Journal of Clinical Pharmacology

    Volume 48, Issue 11, November 2008, Pages: 1309–1322, Dr Shashank Rohatagi, Dr James Lee, Dr Magdy Shenouda, Dr Stephen Haworth, Dr Mohinder Singh Bathala, Dr Mark Allison, Dr Igor Rubets, Dr Reinilde Heyrman, Dr Robert Noveck and Dr Daniel E. Salazar

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008322176

  8. Evaluation of Population Pharmacokinetics and Exposure-Response Relationship With Coadministration of Amlodipine Besylate and Olmesartan Medoxomil

    The Journal of Clinical Pharmacology

    Volume 48, Issue 7, July 2008, Pages: 823–836, Dr Shashank Rohatagi, Dr Timothy J. Carrothers, Dr Smita Kshirsagar, Dr Tatiana Khariton, Dr James Lee and Dr Daniel Salazar

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008317847

  9. You have free access to this content
    Olmesartan-associated enteropathy: results of a national survey

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 9, November 2014, Pages: 1103–1109, L. Marthey, G. Cadiot, P. Seksik, P. Pouderoux, J. Lacroute, F. Skinazi, B. Mesnard, J. A. Chayvialle, G. Savoye, A. Druez, D. Parlier, V. Abitbol, M. Gompel, M. Eoche, E. Poncin, R. Bobichon, P. Colardelle, P. Wils, H. Salloum, S. Peschard, F. Zerbib, B. Méresse, N. Cerf-Bensussan, G. Malamut and F. Carbonnel

    Version of Record online : 9 SEP 2014, DOI: 10.1111/apt.12937

  10. Retracted: Effects of an olmesartan/amlodipine fixed dose on blood pressure control, some adipocytokines and interleukins levels compared with olmesartan or amlodipine monotherapies

    Journal of Clinical Pharmacy and Therapeutics

    Volume 38, Issue 1, February 2013, Pages: 48–55, G. Derosa, A. F. G. Cicero, A. Carbone, F. Querci, E. Fogari, A. D’Angelo and P. Maffioli

    Version of Record online : 5 DEC 2012, DOI: 10.1111/jcpt.12021

  11. The effects of colesevelam HCl on the single-dose pharmacokinetics of glimepiride, extended-release glipizide, and olmesartan medoxomil

    The Journal of Clinical Pharmacology

    Volume 54, Issue 1, January 2014, Pages: 61–69, Ling He, Prachi Wickremasingha, James Lee, Ben Tao, Jeanne Mendell-Harary, Joseph Walker and Douglas Wight

    Version of Record online : 12 OCT 2013, DOI: 10.1002/jcph.180

  12. You have free access to this content
    Angiotensin II-induced modulation of endothelium-dependent relaxation in rabbit mesenteric resistance arteries

    The Journal of Physiology

    Volume 548, Issue 3, May 2003, Pages: 893–906, Takeo Itoh, Junko Kajikuri, Toyohiro Tada, Yoshikatsu Suzuki and Yoshio Mabuchi

    Version of Record online : 19 JUL 2004, DOI: 10.1111/j..2003.t01-1-00893.x

  13. Pharmacokinetics and safety of olmesartan medoxomil in combination with either amlodipine or atenolol compared to respective monotherapies in healthy subjects

    Fundamental & Clinical Pharmacology

    Volume 23, Issue 6, December 2009, Pages: 767–774, Juliane Bolbrinker, Matthias Huber, Jürgen Scholze and Reinhold Kreutz

    Version of Record online : 31 JUL 2009, DOI: 10.1111/j.1472-8206.2009.00720.x

  14. You have free access to this content
    Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptor

    British Journal of Pharmacology

    Volume 151, Issue 7, August 2007, Pages: 952–962, M T Le, M K Pugsley, G Vauquelin and I Van Liefde

    Version of Record online : 17 FEB 2009, DOI: 10.1038/sj.bjp.0707323

  15. Effect of Nisoldipine and Olmesartan on Endothelium-Dependent Vasodilation in Essential Hypertensive Patients

    CNS Neuroscience & Therapeutics

    Volume 18, Issue 5, May 2012, Pages: 400–405, Duo Wei, Wan-Yuan He and Qian-Zhou Lv

    Version of Record online : 25 APR 2012, DOI: 10.1111/j.1755-5949.2012.00304.x

  16. You have free access to this content
    Angiotensin receptor blockers suppress antigen-specific T cell responses and ameliorate collagen-induced arthritis in mice

    Arthritis & Rheumatism

    Volume 52, Issue 6, June 2005, Pages: 1920–1928, Kayo Sagawa, Katsuya Nagatani, Yoshinori Komagata and Kazuhiko Yamamoto

    Version of Record online : 2 JUN 2005, DOI: 10.1002/art.21040

  17. Sustained 24-hour blockade of the renin-angiotensin system: A high dose of a long-acting blocker is as effective as a lower dose combined with an angiotensin-converting enzyme inhibitor

    Clinical Pharmacology & Therapeutics

    Volume 78, Issue 5, November 2005, Pages: 501–507, Christopher Hasler, Jürg Nussberger, Marc Maillard, Andrei Forclaz, Hans R. Brunner and Michel Burnier

    Version of Record online : 18 NOV 2005, DOI: 10.1016/j.clpt.2005.08.001

  18. The Use of Modeling and Simulation to Guide Clinical Development of Olmesartan Medoxomil in Pediatric Subjects

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 2, February 2012, Pages: 250–256, D E Salazar, S H Song, J Shi, S Rohatagi, R Heyrman, D R Wada and T J Carrothers

    Version of Record online : 28 DEC 2011, DOI: 10.1038/clpt.2011.220

  19. You have full text access to this OnlineOpen article
    Linear mixed-effects model of QTc prolongation for olmesartan medoxomil

    The Journal of Clinical Pharmacology

    Volume 56, Issue 1, January 2016, Pages: 96–100, SaeHeum Song, Nobuko Matsushima, James Lee and Jeanne Mendell

    Version of Record online : 24 AUG 2015, DOI: 10.1002/jcph.572

  20. Synergistic neuroprotective effects of combined treatment with olmesartan plus azelnidipine in stroke-prone spontaneously hypertensive rats

    Journal of Neuroscience Research

    Volume 92, Issue 10, October 2014, Pages: 1330–1337, Yoshio Omote, Kentaro Deguchi, Syoichiro Kono, Wentao Liu, Tomoko Kurata, Nozomi Hishikawa, Toru Yamashita, Yoshio Ikeda and Koji Abe

    Version of Record online : 20 MAY 2014, DOI: 10.1002/jnr.23406